← Back to Search

Head Positioning for Intracranial Pressure Due to Brain Bleeds

N/A
Recruiting
Led By Cain Dudek, BS
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years old
Be older than 18 years old
Must not have
Intubated patients who are prone
Patients with left ventricular ejection fraction <20% as evidenced by echocardiogram previously documented at any time in the electronic medical record
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured every fifteen seconds for twenty minutes.
Awards & highlights
No Placebo-Only Group

Summary

This trial will test how head position affects pressure in the brain of people with brain bleeds.

Who is the study for?
This trial is for adults over 18 with a confirmed subarachnoid hemorrhage who have devices to monitor skull pressure and arterial blood pressure. They must be able to consent or have someone who can. Excluded are those prone while intubated, with severe heart failure, pulmonary hypertension, clinical instability, multiple IV meds for blood pressure, active resuscitation, or serious liver issues.
What is being tested?
The study tests how different body positions affect intracranial pressure in patients with brain bleeds. Positions include lying flat (supine), semi-reclined sitting up slightly (semi-recumbent), and semi-reclined with legs bent.
What are the potential side effects?
Potential side effects may relate to discomfort from position changes or adverse reactions due to increased intracranial pressure during the trial procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am on a breathing machine and can be laid face down.
Select...
My heart's pumping ability is very low.
Select...
I have been diagnosed with high blood pressure in the lungs.
Select...
I have cirrhosis or signs of liver failure, such as fluid in the abdomen, swelling, or abnormal blood tests.
Select...
I can lie flat for 30 minutes and am not on multiple IV meds for blood pressure or being resuscitated.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during hospitalization, maximum ten sequential days.
This trial's timeline: 3 weeks for screening, Varies for treatment, and during hospitalization, maximum ten sequential days. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Response of Intracranial Pressure to Positional Changes During Hospitalization
Secondary study objectives
Do Patients Experiencing Vasospasm Have Similar ICP Responses to Positional Changes?

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Positional ChangesExperimental Treatment3 Interventions
The patient will begin in a supine position with the head-of-bed (HOB) at zero (0) degrees. The patient will remain in this position for five (5) minutes while pressure data is collected every fifteen (15) seconds. Next, the HOB will be adjusted to thirty (30) degrees. The patient will remain in this position for five (5) minutes while pressure data is collected every fifteen (15) seconds. Lastly, the HOB will remain at thirty (30) degrees and the foot-of-bed (FOB) will be adjusted to place the patient's leg in a dependent position. The patient will remain in this position for five (5) minutes while pressure data is collected every fifteen (15) seconds.

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
510 Previous Clinical Trials
2,796,459 Total Patients Enrolled
Cain Dudek, BSPrincipal InvestigatorPenn State Hershey Medical Center College of Medicine

Media Library

Positional Changes Clinical Trial Eligibility Overview. Trial Name: NCT05604404 — N/A
Brain Aneurysm Research Study Groups: Positional Changes
Brain Aneurysm Clinical Trial 2023: Positional Changes Highlights & Side Effects. Trial Name: NCT05604404 — N/A
Positional Changes 2023 Treatment Timeline for Medical Study. Trial Name: NCT05604404 — N/A
~7 spots leftby Mar 2026